Item 2 Issuer Principal Place of Business and Contact Information
11500 OLYMPIC BOULEVARD
LOS ANGELES, CA 90064
Phone Number:
subscription required
Item 3. Related Persons
Name
ANTHONY CATALDO
Address
subscription required
Relationship(s)
DIRECTOR
EXECUTIVE OFFICER
Clarification of Response
Item 3. Related Persons
Name
MICHAEL HANDELMAN
Address
subscription required
Relationship(s)
DIRECTOR
EXECUTIVE OFFICER
Clarification of Response
Item 3. Related Persons
Name
DR. L. STEPHEN COLES
Address
subscription required
Relationship(s)
DIRECTOR
Clarification of Response
Item 3. Related Persons
Name
DR. WILLIAM ANDREWS
Address
subscription required
Relationship(s)
DIRECTOR
Clarification of Response
Item 4. Industry Group
BIOTECHNOLOGY
Item 5. Issuer Size
Revenue Range (for issuer not specifying "hedge" or "other investment" fund in Item 4 above)
NO REVENUES
Item 6. Federal Exemptions and Exclusions Claimed
06
Item 7. Type of Filing
New Notice
Date of First Sale in this Offering:
04/17/2011
Item 8. Duration of Offering
Does the issuer intend this offering to last more than one year?
No
Item 9. Type(s) of Securities Offered
Equity
Option, Warrant or Other Right to Acquire Another Security
Item 10. Business Combination Transaction
Is this offering being made in connection with a business combination
transaction, such as a merger, acquisition or exchange offer?
No
Clarification of Response
Item 11. Minimum Investment
Minimum Investment accepted from any outside investor
0
Item 13. Offering and Sales Amounts
Total Offering Amount
1000000
Total Amount Sold
500000
Total Remaining to be Sold
500000
Clarification of Response
Item 14. Investors
Securities in the offering have been or may be sold to persons
who do not qualify as accredited investors,
Number of non-accredited investors who already have invested in the offering:
Total number of investors who already have invested in the offering:
1
Item 15. Sales Commissions and Finders' Fees Expenses
Sales Commissions:
0.0
Finders' Fees
0.0
Clarification of Response
Item 16. Use of Proceeds
Provide the amount of the gross proceeds of the offering
that has been or is proposed to be used for payments to any of the persons required
to be named as executive officers,directors or promoters in response to Item 3 above.
0.0
Clarification of Response
Signature and Submission
Notice has been signed on behalf by the undersigned duly authorized person